Effects of Limicol on LDL-cholesterol

Lescuyer Laboratory47 enrolled

Overview

The principal objective of this study is to investigate the effects of a novel food supplement (Limicol) on LDL-cholesterol levels in healthy subjects with moderate hypercholesterolemia.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

TRIPLE

Enrollment

Conditions

Hypercholesteremia

Interventions

LimicolDIETARY_SUPPLEMENT

3 tablets / day during 4 months

PlaceboDIETARY_SUPPLEMENT

3 tablets / day during 4 months

Eligibility

Sex: ALLMin age: 18 YearsMax age: 55 YearsHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criteria: * About 18 to 55 years (inclusive) * Subject has a stable weight for at least three months before the start of the study * Subject able and willing to comply with the protocol and agreeing to give their consent in writing * Subject affiliated with a social security scheme * Subject willing to be included in the national register of volunteers who lend themselves to biomedical research

Locations (1)

Morange

Marseille, France

Outcomes

Primary Outcomes

Change from Baseline in blood LDL-cholesterol levels at 4 months

Time frame: 4 months

Secondary Outcomes

Change from Baseline in blood Vit. C, Vit. E, polyphenols and MDA levels at 4 months

Time frame: 4 months

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.